Obesity and Diabetes
Researchers from Novo Nordisk, Department of Pharmacology discuss findings in obesity and diabetes
Published in Fitness and Wellness Business Week, February 7th, 2007
Current study results from the report, "Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not," have been published. "Metabolic effects of the glucagon-like peptide-1 analog liraglutide and the dipeptidyl peptidase-IV inhibitor vildagliptin were compared in rats made obese by supplementary candy feeding. Female Sprague-Dawley rats were randomized to 12-week diets of chow or chow plus candy," scientists writing in the journal Diabetes report.
"The latter were randomized for 12 further weeks to continue their diet while receiving 0.2...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Fitness and Wellness Business Week
More Articles from Fitness and Wellness Business Week
- Adipose Tissue
New adipose tissue data have been reported by researchers at University of Oviedo - Adipose Tissue
Research on adipose tissue described by scientists at National Research Council - Adipose Tissue
Research on adipose tissue published by scientists at University of Barcelona - Allergies Immunology
Research reports from Norwegian Institute of Public Health, Division of Environmental Medicine provide new insights into allergies immunology - Allergies Prevention
Findings from Philipps University, Biomedical Research Center provide new insights into allergies prevention - Allergies Therapy
Data on allergies therapy published by researchers at University of Heidelberg - More from this issue of Fitness and Wellness Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
